Pegah Golabi - Concepedia

Author

Pegah Golabi

Inova Health System ORCID

Also Known As

P Golabi, P. Golabi, PEGAH GOLABI, Parsa Golabi, Pegah Golabi, Pejman Golabi

162

Publications

10.8K

Citations

H-Index

Concepts

All Affiliations

Inova Health System Inova Fairfax Hospital Center for Outcomes Research in Liver Diseases Johns Hopkins University King Faisal Specialist Hospital & Research Centre

About

Pegah Golabi is an author at Inova Health System specializing in medicine, hepatology, and nonalcoholic fatty liver disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	14	1.1K
2	Health Sciences	7	7	478
3	Public Health	7	7	478
4	Diabetes	3	3	257
5	Cognitive Science	1	1	47

Pegah Golabi

Publications

3.9K

Citations

H-Index

Page 1

	Year	Citations
Epidemiology of chronic liver diseases in the USA in the past three decades Zobair M. Younossi, Maria Stepanova, Youssef Younossi, Gut	2019	535
Mortality assessment of patients with hepatocellular carcinoma according to underlying disease and treatment modalities Pegah Golabi, Sofie Fazel, Munkhzul Otgonsuren, Medicine Surgical OncologyLiverHepatologyUnderlying DiseaseHcc.the Aim	2017	257
Burden of non-alcoholic fatty liver disease in Asia, the Middle East and North Africa: Data from Global Burden of Disease 2009-2019 Pegah Golabi, James M. Paik, Saleh A. Alqahtani, Journal of Hepatology ObesityMetabolic SyndromeGlobal BurdenMetabolic Associated SteatohepatitisHepatic Disorders	2021	239
Components of metabolic syndrome increase the risk of mortality in nonalcoholic fatty liver disease (NAFLD) Pegah Golabi, Munkhzul Otgonsuren, Leyla de Avila, Medicine	2018	206
Are there outcome differences between NAFLD and metabolic‐associated fatty liver disease? Zobair M. Younossi, James M. Paik, Reem Q. Al Shabeeb, Hepatology	2022	173
Non-alcoholic Fatty Liver Disease (NAFLD) is associated with impairment of Health Related Quality of Life (HRQOL) Pegah Golabi, Munkhzul Otgonsuren, Rebecca Cable, Health and Quality of Life Outcomes	2016	142
Contribution of sarcopenia and physical inactivity to mortality in people with non-alcoholic fatty liver disease Pegah Golabi, Lynn H. Gerber, James M. Paik, JHEP Reports	2020	125
Prevalence and long-term outcomes of non-alcoholic fatty liver disease among elderly individuals from the United States Pegah Golabi, James M. Paik, Rashmi Reddy, BMC Gastroenterology	2019	124
Patients With Lean Nonalcoholic Fatty Liver Disease Are Metabolically Abnormal and Have a Higher Risk for Mortality Pegah Golabi, James M. Paik, Natsu Fukui, Clinical Diabetes Metabolic DisorderFatty Liver DiseaseObesityMetabolic SyndromeHigher Risk	2018	121
Mortality of NAFLD According to the Body Composition and Presence of Metabolic Abnormalities Pegah Golabi, James M. Paik, Tamoore Arshad, Hepatology Communications	2020	95

Page 1